Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26,475,256
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
7,464,652
-
Shares change
-
-893,808
-
Total reported value, excl. options
-
$89,542,714
-
Value change
-
-$12,879,299
-
Put/Call ratio
-
0%
-
Number of buys
-
26
-
Number of sells
-
-28
-
Price
-
$11.98
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q4 2021
73 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q4 2021.
AVITA Medical, Inc. - Common Stock (RCEL) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7,464,652 shares
of 26,475,256 outstanding shares and own 28.19% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,588,592 shares), VANGUARD GROUP INC (1,270,510 shares), FARALLON CAPITAL MANAGEMENT LLC (800,000 shares), STATE STREET CORP (783,005 shares), Redmile Group, LLC (672,411 shares), Blackcrane Capital, LLC (454,871 shares), GEODE CAPITAL MANAGEMENT, LLC (421,920 shares), NORTHERN TRUST CORP (228,809 shares), RTW INVESTMENTS, LP (106,667 shares), and Allianz Asset Management GmbH (88,147 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.